Molecular and Cellular Mechanisms of Browning of Adipocytes in Metabolic Health and Disease

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: closed (15 July 2025) | Viewed by 293

Special Issue Editors


E-Mail Website
Guest Editor
Division of Stem Cell Biology, Institute for Genetic Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo 060-0815, Hokkaido, Japan
Interests: adipocyte differentiation; adipose stromal vascular fraction; adipose tissue remodeling; obesity; aging; molecular endocrinology

E-Mail Website
Guest Editor
Laboratory of Biochemistry, Faculty of Veterinary Medicine, Hokkaido University, Kita-18, Nishi-9, Kita-ku, Sapporo 060-0818, Hokkaido, Japan
Interests: hibernation/torpor; metabolic syndrome; cell proliferation; thermolegulation; brown adipose tissue; adipocyte; obesity; metabolism

Special Issue Information

Dear Colleagues,

Adipose tissue is a central and dynamic organ in the regulation of whole-body energy homeostasis and metabolism. Therefore, metabolic health is closely linked to the balance between energy-storing white adipose tissue (WAT) and energy-burning brown adipose tissue (BAT). Following the identification of metabolically active BAT in adult humans in 2009, there have been significant advances in our understanding of the dynamics of BAT. Given its metabolic efficacy, the expansion of BAT and the activation of existing BAT has attracted considerable interest as a potential therapeutic strategy to promote energy expenditure and counteract complications associated with metabolic disorders. Studies have demonstrated that mature adipocytes can undergo transdifferentiation into a brown-like phenotype (i.e., beige adipocytes) in response to specific stimuli, including cold exposure, dietary change, exercise, hormonal regulation, and drug treatment. This process, known as the browning of white adipocytes, involves a complex series of cellular and molecular events, including the activation of the thermogenic pathway, mitochondrial biogenesis, increased lipolysis and fatty acid oxidation, and the expression of BAT-specific transcription factors.

The aim of this Special Issue is to present the current understanding of BAT metabolism and its regulation, based on studies conducted in humans, animal models, or in vitro models. Particular emphasis will be placed on the molecular mechanisms by which the dysfunctional BAT promotes metabolic disorders such as obesity, aging, and inflammation. We also welcome submissions exploring novel approaches, including pharmaceuticals, nutraceuticals, and cell/gene therapies aimed at enhancing BAT activity. Both original research articles and comprehensive reviews are encouraged to contribute to this Special Issue.

Dr. You Lee Son
Dr. Yuko Okamatsu-Ogura
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • brown and white adipose tissue, BAT, and WAT
  • brown, beige, and white adipocyte
  • browning of white adipocyte
  • adipocyte differentiation
  • adipose tissue remodeling
  • adipose hyperplasia and hypertrophy
  • metabolic disorders
  • obesity
  • aging
  • inflammation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 1292 KiB  
Article
The Adipose Tissue-Derived Secretome (ADS) in Obesity Uniquely Regulates the Na-Glucose Transporter SGLT1 in Intestinal Epithelial Cells
by Vivian Naa Amua Wellington and Soudamani Singh
Cells 2025, 14(16), 1241; https://doi.org/10.3390/cells14161241 - 12 Aug 2025
Abstract
Obesity is a complex chronic inflammatory condition that results from excess fat accumulation. It increases the risk of developing numerous co-morbidities such as Type 2 diabetes mellitus, cardiovascular disease, hypertension, and stroke. The adipose tissue is itself a vital endocrine organ that secretes [...] Read more.
Obesity is a complex chronic inflammatory condition that results from excess fat accumulation. It increases the risk of developing numerous co-morbidities such as Type 2 diabetes mellitus, cardiovascular disease, hypertension, and stroke. The adipose tissue is itself a vital endocrine organ that secretes numerous adipokines, cytokines, and exosomes, which are collectively known as the adipose-derived secretome (ADS). This ADS has been shown to influence and modulate many physiological processes. During obesity, the composition of ADS is altered, which may contribute to the development of obesity-associated diseases. Type-2 diabetes mellitus is one of the most common complications of obesity due to alterations in glucose homeostasis. Glucose absorption occurs via Na-glucose co-transport via SGLT1 at the brush border membrane (BBM) of small intestinal villus cells. This process of transepithelial glucose uptake is the primary method of glucose absorption from diet. However, how ADS mediates the function of SGLT1 is not yet known. This study aims to determine the mechanism of regulation of SGLT1 by ADS in intestinal epithelial cells. We show that ADS from OZR (but not LZR) stimulates SGLT1 in IEC-18 cells. OZR-ADS treatment diminished Na/K-ATPase activity in IEC-18 cells. Kinetic studies indicated that the mechanism of stimulation for SGLT1 during OZR-ADS treatment was secondary to an increase in the affinity (1/Km) of the co-transporter for glucose without a change in co-transporter number. Western blot studies revealed that SGLT1 protein expression was unaltered in the two groups, confirming our kinetic studies. Immunoprecipitation demonstrated that an increase in the affinity of the SGLT1 protein was mediated by altered phosphorylation. In conclusion, during obesity, the adipose tissue secretome stimulates SGLT1 in intestinal epithelial cells, leading to an increase in affinity for glucose. The affinity change is due to alterations in SGLT1 phosphorylation. Together, these results may provide important insight into the mechanisms underlying altered glucose homeostasis in obesity and how this may lead to the development of Type 2 diabetes mellitus. Full article
Show Figures

Figure 1

Back to TopTop